Wegener’s Granulomatosis Etanercept

Seo P, Min YI, Holbrook JT, et al. Damage caused by Wegener s granulomatosis and its treatment prospective data from the Wegener s Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 2005 52(7) 2168 178. [Pg.637]

Stone JH. Limited versus severe Wegener s granulomatosis baseUne data on patients in the Wegener s granulomatosis etanercept trial. Arthritis Rheum 2003 48(8) 2299-2309. [Pg.637]

Stone JH, Holbrook JT, Marriott MA, et al. Solid malignancies among patients in the Wegener s Granulomatosis Etanercept Trial. Arthritis Rheum 2006 54(5) 1608-1618. [Pg.637]

The US manufacturers say that etanercept is not recommended in patients receiving cyclophosphamide. They state that in a study in patients with Wegener s granulomatosis, the addition of etanercept to standard treatment, including cyclophosphamide, was associated with a higher incidence of non-cutaneous solid malignancies. ... [Pg.1062]

Etanercept plus standard therapy for Wegener s granulomatosis. N Engl J Med 2005 352(4) 351-361. [Pg.630]

Stone JH, Uhlfelder ML, HeUmann DB, et al. Etanercept combined with conventional treatment in Wegener s granulomatosis a six-month open-label trial to evaluate safety. Arthritis Rheum 2001 44(5) 1149-1154. [Pg.639]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...